Far-Field EGM Oversensing Detection in Implantable Cardiac Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac devices face challenges in accurately distinguishing between appropriate and inappropriate arrhythmia detections due to oversensing of cardiac and non-cardiac events, leading to potential unnecessary therapies and patient discomfort.
Innovation Solution
An automated method for analyzing far-field electrogram signals to detect and classify oversensing, comparing these signals to near-field signals and using template matching to identify types of oversensing such as far-field R-wave, T-wave, and non-cardiac causes like electromagnetic interference or lead issues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the ICD uses sensitive sensing to detect arrhythmias, then arrhythmia detection capability is improved, but oversensing of non-cardiac events increases leading to inappropriate therapies
Solution Approach 1:
The patent introduces an intermediary analysis system that compares far-field EGM signals against stored templates of known cardiac and non-cardiac patterns. This intermediary layer filters out false positives by matching signal characteristics against reference data, allowing the system to maintain high sensitivity while reducing oversensing of non-cardiac events through template-based verification.
Solution Approach 2:
The system implements feedback by continuously analyzing far-field EGM signals and comparing them against stored templates to verify detected arrhythmias. The analysis results feed back into the therapy delivery decision-making process, allowing the ICD to confirm or reject potential arrhythmia detections before initiating treatment, thereby reducing inappropriate therapies.
2Reliability
If the ICD delivers therapy in response to detected arrhythmias, then life-saving treatment is provided, but inappropriate therapies cause patient discomfort and potential arrhythmia induction
Solution Approach 1:
The patent applies preliminary action by performing far-field EGM analysis and template matching before therapy delivery. The system pre-analyzes the signal characteristics and compares them against stored templates to verify the validity of the detected arrhythmia, ensuring that therapy is only delivered when the detection is confirmed as appropriate, thereby preventing inappropriate treatments.
Solution Approach 2:
The system uses feedback from far-field EGM analysis to verify arrhythmia detections before initiating therapy. The analysis results feed back into the decision-making process, allowing the ICD to confirm or reject potential arrhythmia detections, thereby reducing inappropriate therapies and their associated harmful effects.
3Measurement precision
If the ICD stores and analyzes EGM signals for arrhythmia detection, then diagnostic accuracy is improved, but device complexity and data processing requirements increase
Solution Approach 1:
The patent uses copying by storing templates of known cardiac and non-cardiac EGM patterns for comparison. Instead of analyzing every signal from scratch, the system compares detected far-field EGM signals against stored template copies, significantly simplifying the real-time analysis process while maintaining high diagnostic precision through pattern recognition.
Solution Approach 2:
The system applies parameter changes by transforming the EGM signals into a format suitable for template comparison, extracting key characteristics and modifying the signal representation to facilitate efficient pattern matching. This transformation simplifies the complexity of direct signal analysis while maintaining detection precision.
Data Source
AI summary
A method for identifying and classifying various types of oversensing in implantable medical devices (IMDs), such as implantable cardioverter defibrillators (ICDs), to assist a physician in choosing corrective action to reduce the likelihood of oversensing and inappropriate therapy delivery. Far-field electrogram (EGM) signals are analyzed to detect the occurrence of R-waves, and the result is compared to the number and pattern of R-waves sensed by the IMD and indicated on the marker channel. A marker channel with more sensed R-waves than indicated by analysis of the far-field EGM indicates the presence of oversensing, including double-counting of R-waves, T-wave oversensing, lead malfunction or failure, poor lead connections, noise associated with electromagnetic interference, non-cardiac myopotentials, etc. Identification of the type of oversensing may be determined by analysis of the number and pattern of marker channel sensed R-waves with respect to the timing of the R-waves detected from the far-field EGM.